Searched for
DAPAGLIFLOZIN
Good news for diabetes & BP patients: Govt cuts prices of these 30 medicines, relief may reach pharmacies soonThe National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices for 30 essential drug formulations, including those for diabet...- Lupin launches generic anti-diabetic tablets in USPharma major Lupin has launched its generic anti-diabetic medicine in the United States. The medicine is dapagliflozin and metformin hydroc...
- Stocks in news: Torrent Power, GAIL, J&K Bank, Ola Electric, Vedanta, InfosysMarkets ended higher for the third consecutive session amidst volatility. Today's trade will focus on ceasefire developments and the MPC me...
- Zydus Lifesciences hits the sweet spot after approval for generic diabetes drugZydus Lifesciences has achieved a significant milestone by obtaining tentative approval from the US FDA for Dapagliflozin Tablets. Designed...
- Cipla, Natco Pharma, Hetero Labs among Indian firms chosen to supply key generic drugs in ChinaIndian firms Hetero Labs Limited, Cipla Ltd, Annora Pharma Private Limited and Natco Pharma won the bids conducted by the Chinese health mi...
- Glenmark launches triple-drug combo for type 2 diabetesGlenmark Pharmaceuticals has launched a triple-fixed-dose combination drug called Zita for the treatment of Type 2 diabetes. The drug, whic...
- AstraZeneca gets GCGI approval to import heart failure drugAstraZeneca Pharma India on Monday said it has received approval from the Drugs Controller General of India to import heart failure treatme...
- Glenmark Pharma launches drug for diabetic patients with comorbiditiesThe new drug is well researched and affordable fixed-dose combination, which will significantly improve glycemic control in adult patients,...
- AstraZeneca working on vaccine to prevent and cure Covid: MD Gagandeep SinghAnglo-Swedish pharma company AstraZeneca has mobilised research efforts to advance the development of a novel coronavirus-neutralising long...
- High court order on diabetes drug patent may reduce pricesThe cost for treating diabetes is expected to come down with the Delhi high court having dismissed an appeal by AstraZeneca, which had soug...
- Sun Pharma acquires rights to trademarks of three diabetes drug brands in India from AstraZeneca"Sun Pharma has now acquired the rights to trademarks Oxra, Oxramet and Oxraduo in India from AstraZeneca AB, Sweden, parent company of Ast...
- AstraZeneca Pharma, Abbott Healthcare terminate distribution agreements for diabetes drug in IndiaAstraZeneca India will continue to independently market Dapagliflozin, the combinations of Dapagliflozin and Metformin as well as Dapaglifl...
- Astrazeneca gets marketing authorisation to use anti-diabetes drug for kidney diseaseThe drug is the first medicine in SGLT-2i class to move into a new disease area by demonstrating efficacy and safety data for the treatment...
- AstraZeneca's Dapagliflozin tablets get DCGI nod for patients with chronic kidney diseaseThe company has "received Import and Market Permission in Form CT-20 (Subsequent New Drug Approval) from the DCGI for Dapagliflozin tablets...
- Zydus Healthcare launches generic anti-diabetic Dapagliflozin tablets in IndiaThe once-daily tablets are indicated as an adjunct to diet and exercise, and aim to improve glycemic control in adults with Type 2 diabetes...
- Glenmark Pharma gets tentative USFDA nod for generic anti-diabetes tabletsGlenmark Pharmaceuticals on Wednesday said it has received tentative approval from the US health regulator for its generic Dapagliflozin an...
- Natco launches cut-price copies of AstraZeneca's patented anti-diabetes drugThe launch gives Natco an entry in the rapidly growing SGLT-2 segment that has mostly been dominated by global drug makers. However, for ro...
- Alembic Pharma gets tentative nod from USFDA for glycemic control drugQuoting IQVIA sales data, the company said, Dapagliflozin Tablets, have an estimated market size of USD 1.7 billion for 12 months, ending D...
- Sun Pharma, AstraZeneca tie up to sell latest anti-diabetes drug DapagliflozinDiabetes estimated to affect approximately 69.2 million people in India and more than 415 million people worldwide.
- Three new diabetes drugs come under the scanner of US drug regulatorThe other existing medicines for type-2 diabetes do not work through kidneys and rather use pancreas as a pathway.
Load More
